BioCatalystWatch
NERVWorkspace / NERV / OverviewCompany library
Minerva Neurosciences, Inc. logo

Minerva Neurosciences, Inc.

Minerva Neurosciences, Inc. (NERV)

Website

Price
Market cap
Next catalystMDD3003 estimated primary-outcome completion: December 2026seltorexant — MDD3003 adjunctive treatment · Study completionSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

roluperidone

5-HT2A × Sigma-2 receptor × Alpha-1A adrenergic receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

roluperidone

5-HT2A × Sigma-2 receptor × Alpha-1A adrenergic receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Partner / License out

Orexin-2 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Orexin-2 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Orexin-2 receptor

PreINDP1P2P3FilingApproved

Orexin-2 receptor

PreINDP1P2P3FilingApproved

Orexin-2 receptor

PreINDP1P2P3FilingApproved

5-HT1A × 5-HT2A × Alpha-1A adrenergic receptor × Alpha-1B adrenergic receptor × Dopamine transporter

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

NERV PR & News

PR & News

NERV SEC archive